Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-799]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Microgenics Corporation Thermo Fisher Scientific has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 31, 2021. Such persons may also file a written request for a hearing on the application on or before March 31, 2021.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on January 27, 2021, Microgenics Corporation Thermo Fisher Scientific, 46500 Kato Road Fremont, California 94538, has applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance
Drug code
ScheduleCathinone
1235
IMephedrone (4-Methyl-N-methylcathinone)
1248
IGamma Hydroxybutyric Acid
2010
IMethaqualone
2565
IMecloqualone
2572
I2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate
7021
IAB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)
7023
IAB-CHMINACA (N-(1-amino-3-methyl-1-≤oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
7031
IMAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
7032
I5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate)
7033
IADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)
7035
IAPINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
7048
IAM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)
7201
ILysergic acid diethylamide
7315
IMarihuana
7360
ITetrahydrocannabinols
7370
I3,4-Methylenedioxyamphetamine
7400
I3,4-Methylenedioxy-N-ethylamphetamine
7404
I3,4-Methylenedioxymethamphetamine
7405
I2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
7518
IMDPV (3,4-Methylenedioxypyrovalerone)
7535
I2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)
7538
IButylone
7541
IPentylone
7542
Ialpha-pyrrolidinopentiophenone (α-PVP)
7545
INormorphine
9313
I( print page 12034)AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))
9551
IAcetylmethadol
9601
IAlphamethadol
9605
IKetobemidone
9628
INoracymethadol
9633
IPara-Fluorofentanyl
9812
I3-Methylfentanyl
9813
IAlpha-methylfentanyl
9814
IAcetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
9821
I2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
9825
I3-Methylthiofentanyl
9833
ICyclopropyl Fentanyl
9845
IFentanyl related-compounds as defined in 21 CFR 1308.11&h)
9850
IAmphetamine
1100
IIMethamphetamine
1105
IIMethylphenidate
1724
IIAmobarbital
2125
IIPentobarbital
2270
IISecobarbital
2315
IIPhencyclidine
7471
IICocaine
9041
IICodeine
9050
IIDihydrocodeine
9120
IIOxycodone
9143
IIHydromorphone
9150
IIEcgonine
9180
IIHydrocodone
9193
IILevorphanol
9220
IIMeperidine
9230
IIMeperidine intermediate-B
9233
IIMethadone
9250
IIDextropropoxyphene, bulk (non-dosage forms)
9273
IIMorphine
9300
IIThebaine
9333
IILevo-alphacetylmethadol
9648
IIOxymorphone
9652
IICarfentanil
9743
IITapentadol
9780
IIFentanyl
9801
II
 The company plans to import the listed controlled substances for feasibility studies for new products and cross reactivity studies for existing products. The products will serve as raw materials for In Vitro Diagnostic quantitative assay. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of the Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator.


[FR Doc. 2021-04147 Filed 2-26-21; 8:45 am] BILLING CODE P